Kristina Baraba Dekanić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kristina Baraba Dekanić has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Goran Palčevski
Clinical Hospital Center Rijeka
3 shared publications - Ivona Butorac Ahel
Department of Pediatrics, Clinical Hospital Centre Rijeka
3 shared publications - Ivona Butorac Ahel
Clinical Hospital Center Rijeka
3 shared publications - Kristina Lah Tomulić
Klinički bolnički centar Rijeka, Medicinski fakultet Sveučilišta u Rijeci
3 shared publications Goran Palčevski
Department of Pediatrics, University Hospital Center Rijeka, Istarska 43, 51 000 Rijeka, Croatia
2 shared publications- Inge Vlašić-Cicvarić
Faculty of Medicine, University of Rijeka, Braće Branchetta 20, 51000 Rijeka, Croatia
2 shared publications
Latest Publications
- Open Access
Incidence and Risk Factors for Glucose Disturbances in Premature Infants
Background and Objectives: There are limited data regarding the incidence and risk factors for hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants. The aim of the present study was to determine the incidence and risk factors associated with neonatal hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants during the first seven days of life. Materials and Methods: This prospective study included preterm infants <37 weeks of gestation, admitted to the Neonatal Intensive Care Unit between January 2018 and December 2020. Based on blood glucose levels in the first week of life, infants were divided into the following four groups: normoglycemic, hypoglycemic, hyperglycemic, and unstable. Blood glucose levels were measured from capillary blood at the 1st, 3rd, 6th, and 12th hour of life during the first 24 h, and at least once a day from days 2 to 7, prefeed. Results: Of 445 enrolled infants, 20.7% (92/445) were categorized as hypoglycemic, 9.9% (44/445) as hyperglycemic, and 2.9% (13/445) as unstable, respectively. Hypoglycemia was most commonly observed among infants ≥34 weeks (27.9%), and hyperglycemia was most common among preterm infants <28 weeks (50%). Female gender increased the chances of developing hypoglycemia by three times. The decrease in gestational age by one week increased the chance of developing hyperglycemia by 1.9 times. Sepsis increased the chance of developing hyperglycemia seven times, respiratory distress syndrome five times, and mechanical ventilation three times, respectively. Conclusions: Glucose disturbances in the early neonatal period in preterm infants are common and mostly asymptomatic. Therefore, careful blood glucose level monitoring is required in those infants, especially in late preterm infants, in order to prevent possible neurological complications.
Open AccessIncidence and Risk Factors for Glucose Disturbances in Premature Infants
Background and Objectives: There are limited data regarding the incidence and risk factors for hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants. The aim of the present study was to determine the incidence and risk factors associated with neonatal hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants during the first seven days of life. Materials and Methods: This prospective study included preterm infants <37 weeks of gestation, admitted to the Neonatal Intensive Care Unit between January 2018 and December 2020. Based on blood glucose levels in the first week of life, infants were divided into the following four groups: normoglycemic, hypoglycemic, hyperglycemic, and unstable. Blood glucose levels were measured from capillary blood at the 1st, 3rd, 6th, and 12th hour of life during the first 24 h, and at least once a day from days 2 to 7, prefeed. Results: Of 445 enrolled infants, 20.7% (92/445) were categorized as hypoglycemic, 9.9% (44/445) as hyperglycemic, and 2.9% (13/445) as unstable, respectively. Hypoglycemia was most commonly observed among infants ≥34 weeks (27.9%), and hyperglycemia was most common among preterm infants <28 weeks (50%). Female gender increased the chances of developing hypoglycemia by three times. The decrease in gestational age by one week increased the chance of developing hyperglycemia by 1.9 times. Sepsis increased the chance of developing hyperglycemia seven times, respiratory distress syndrome five times, and mechanical ventilation three times, respectively. Conclusions: Glucose disturbances in the early neonatal period in preterm infants are common and mostly asymptomatic. Therefore, careful blood glucose level monitoring is required in those infants, especially in late preterm infants, in order to prevent possible neurological complications.
- Open Access
Epidemiologic Characteristics of Children with Diabetic Ketoacidosis Treated in a Pediatric Intensive Care Unit in a 10-Year-Period: Single Centre Experience in Croatia
Background and Objectives: The incidence of severe and moderate forms of DKA as the initial presentation of type 1 diabetes mellitus (T1D) is increasing, especially during the COVID-19 pandemic. This poses a higher risk of developing cerebral edema as a complication of diabetic ketoacidosis (DKA), as well as morbidity and mortality rates. The aim of this study was to determine the trend and clinical features of children treated in the last 10 years in the Pediatric Intensive Care Unit (PICU) due to the development of DKA. Materials and Methods: This retrospective study was performed in the PICU, Clinical Hospital Centre Rijeka, in Croatia. All children diagnosed with DKA from 2011–2020 were included in this study. Data were received from hospital medical documentation and patient paper history. The number of new cases and severity of DKA were identified and classified using recent International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Results: In this investigation period, 194 children with newly diagnosed T1D were admitted to our hospital: 58 of them were treated in the PICU due to DKA; 48 had newly diagnosed T1D (48/58); and ten previously diagnosed T1D (10/58). DKA as the initial presentation of T1D was diagnosed in 24.7% (48/194). Moderate or severe dehydration was present in 76% of the children at hospital admission. Polyuria, polydipsia, and Kussmaul breathing were the most common signs. Three patients (5.2%) developed cerebral edema, of whom one died. Conclusions: During the investigation period a rising trend in T1D was noted, especially in 2020. About one quarter of children with T1D presented with DKA at initial diagnosis in western Croatia, most of them with a severe form. Good education of the general population, along with the patients and families of children with diabetes, is crucial to prevent the development of DKA and thus reduce severe complications.
Open AccessEpidemiologic Characteristics of Children with Diabetic Ketoacidosis Treated in a Pediatric Intensive Care Unit in a 10-Year-Period: Single Centre Experience in Croatia
Background and Objectives: The incidence of severe and moderate forms of DKA as the initial presentation of type 1 diabetes mellitus (T1D) is increasing, especially during the COVID-19 pandemic. This poses a higher risk of developing cerebral edema as a complication of diabetic ketoacidosis (DKA), as well as morbidity and mortality rates. The aim of this study was to determine the trend and clinical features of children treated in the last 10 years in the Pediatric Intensive Care Unit (PICU) due to the development of DKA. Materials and Methods: This retrospective study was performed in the PICU, Clinical Hospital Centre Rijeka, in Croatia. All children diagnosed with DKA from 2011–2020 were included in this study. Data were received from hospital medical documentation and patient paper history. The number of new cases and severity of DKA were identified and classified using recent International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Results: In this investigation period, 194 children with newly diagnosed T1D were admitted to our hospital: 58 of them were treated in the PICU due to DKA; 48 had newly diagnosed T1D (48/58); and ten previously diagnosed T1D (10/58). DKA as the initial presentation of T1D was diagnosed in 24.7% (48/194). Moderate or severe dehydration was present in 76% of the children at hospital admission. Polyuria, polydipsia, and Kussmaul breathing were the most common signs. Three patients (5.2%) developed cerebral edema, of whom one died. Conclusions: During the investigation period a rising trend in T1D was noted, especially in 2020. About one quarter of children with T1D presented with DKA at initial diagnosis in western Croatia, most of them with a severe form. Good education of the general population, along with the patients and families of children with diabetes, is crucial to prevent the development of DKA and thus reduce severe complications.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A122-A123
289 Hereditary spherocytosis associated with Gilbert syndrome – a case report
Gilbert syndrome (GS) and hereditary spherocytosis (HS) are hereditary diseases with high prevalence rates and similar symptoms. The calculated coexistence of these two diseases is 15-35/million births. Severe hyperbilirubinemia compared with the degree of hemolysis in patients with HS should raise suspicion of associated clinical conditions such as GS, glucose-6-phosphate-dehydrogenase deficiency or thalassemia. We present the case of a 21-month-old girl with HS and GS. The diagnosis of HS was established by osmotic fragility test results in the age of 40 days. During infancy the patient had several hemolytic episodes precipitated by upper respiratory tract infections, requiring transfusion therapy. Bilirubin levels were around 100 mmol/l. At the age of 21 months during viral infection, an unusually high unconjugated hyperbilirubinemia was noticed (total bilirubin/direct level 239/13 mmol/l) with mild anemia in the absence of severe hemolysis. As hyperbilirubinemia could not be explained by hemolysis, further evaluation was performed. Genotyping of the conjugation enzyme uridine diphosphate-glucuronosyltransferase confirmed GS. The girl has been followed-up regularly, with consistently higher values of total bilirubin. A trial with phenobarbitone resulted in a rapid fall in bilirubin levels (below 34 mmol/l) followed. Our case confirms that the possibility of the coexistence of GS and HS should be considered in patients with inappropriately high serum bilirubin levels when compared with the severity of HS.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A122-A123
Open Access289 Hereditary spherocytosis associated with Gilbert syndrome – a case report
Gilbert syndrome (GS) and hereditary spherocytosis (HS) are hereditary diseases with high prevalence rates and similar symptoms. The calculated coexistence of these two diseases is 15-35/million births. Severe hyperbilirubinemia compared with the degree of hemolysis in patients with HS should raise suspicion of associated clinical conditions such as GS, glucose-6-phosphate-dehydrogenase deficiency or thalassemia. We present the case of a 21-month-old girl with HS and GS. The diagnosis of HS was established by osmotic fragility test results in the age of 40 days. During infancy the patient had several hemolytic episodes precipitated by upper respiratory tract infections, requiring transfusion therapy. Bilirubin levels were around 100 mmol/l. At the age of 21 months during viral infection, an unusually high unconjugated hyperbilirubinemia was noticed (total bilirubin/direct level 239/13 mmol/l) with mild anemia in the absence of severe hemolysis. As hyperbilirubinemia could not be explained by hemolysis, further evaluation was performed. Genotyping of the conjugation enzyme uridine diphosphate-glucuronosyltransferase confirmed GS. The girl has been followed-up regularly, with consistently higher values of total bilirubin. A trial with phenobarbitone resulted in a rapid fall in bilirubin levels (below 34 mmol/l) followed. Our case confirms that the possibility of the coexistence of GS and HS should be considered in patients with inappropriately high serum bilirubin levels when compared with the severity of HS.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A99
236 New name, new criteria, old disease: paediatric intestinal pseudoobstruction (PIPO)
Introduction Pediatric intestinal pseudoobstruction (PIPO) is a rare and complex gastrointestinal motility disorder affecting mainly the small intestine and the colon resulting in intestinal failure. Due to severe and reccurent episodes of pseudo-obstruction, children are unable to meet their nutritional needs enterally and might even need parental nutritional support. In 2018, diagnostic criteria were proposed by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition with a goal to improve diagnosis, management and treatment while decreasing morbidity and mortality in these patients. Case Report We present a case of female infant who was referred to the tertiary center for further medical evaluation due to recurrent abdominal distention and subileus at the age of 6 months. Prenatally, the child was diagnosed with megacystis, later evaluated as hypotonic urinary bladder without vesicouretheral reflux and with normal renal function. At four months, she experienced the first intestinal obstruction characterized with severe abdominal distention, stool absence and inability to tolerate enteral feeds. Mechanical obstruction was excluded by radiologic studies. Therefore she was transferred to our center for further diagnostic work-up. In accordance to the guidelines, in our center, rectal biopsy was performed to exclude Hirschsprung’s disease. During initial evaluation, the patient experienced a new episode of distention and not tolerating oral feeds. Radiologic images during the episode showed distended bowel loops throughout the abdomen (Figure 1). She was treated by withholding enteral feed, intravenous fluids and prokinetics. Because of the progressive course of the distension she underwent exploratory laparotomy with formation of decompressive ileostomy at the age of 7 months (Figure 2). Full thickness biopsy were also performed at various site of small and large intestine and showed histological elements of intestinal neuronal dysplasia. In her further clinical course she experienced 3 more episodes treated conservatively, she was not able to tolerate full enteral feeds so we initiated parenteral nutrition to maintain adequate growth. In accordance with disease course so far, our patient met 2 out of 4 listed criteria for pediatric pseudointestinal obstruction, persistently dilated loops of small intestine with air fluid and inability to maintain adequate nutrition and growth via enteral feed. Conclusion To conclude, we present a difficult case of PIPO, with early onset of abdominal distention, need for parenteral nutrition, and bladder involvement with uncertain prognosis. Nevertheless, early recognition of disorder leads to optimal management including formation of venting stoma, prevention of unnecessary repeated surgeries and better nutritional management.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A99
Open Access236 New name, new criteria, old disease: paediatric intestinal pseudoobstruction (PIPO)
Introduction Pediatric intestinal pseudoobstruction (PIPO) is a rare and complex gastrointestinal motility disorder affecting mainly the small intestine and the colon resulting in intestinal failure. Due to severe and reccurent episodes of pseudo-obstruction, children are unable to meet their nutritional needs enterally and might even need parental nutritional support. In 2018, diagnostic criteria were proposed by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition with a goal to improve diagnosis, management and treatment while decreasing morbidity and mortality in these patients. Case Report We present a case of female infant who was referred to the tertiary center for further medical evaluation due to recurrent abdominal distention and subileus at the age of 6 months. Prenatally, the child was diagnosed with megacystis, later evaluated as hypotonic urinary bladder without vesicouretheral reflux and with normal renal function. At four months, she experienced the first intestinal obstruction characterized with severe abdominal distention, stool absence and inability to tolerate enteral feeds. Mechanical obstruction was excluded by radiologic studies. Therefore she was transferred to our center for further diagnostic work-up. In accordance to the guidelines, in our center, rectal biopsy was performed to exclude Hirschsprung’s disease. During initial evaluation, the patient experienced a new episode of distention and not tolerating oral feeds. Radiologic images during the episode showed distended bowel loops throughout the abdomen (Figure 1). She was treated by withholding enteral feed, intravenous fluids and prokinetics. Because of the progressive course of the distension she underwent exploratory laparotomy with formation of decompressive ileostomy at the age of 7 months (Figure 2). Full thickness biopsy were also performed at various site of small and large intestine and showed histological elements of intestinal neuronal dysplasia. In her further clinical course she experienced 3 more episodes treated conservatively, she was not able to tolerate full enteral feeds so we initiated parenteral nutrition to maintain adequate growth. In accordance with disease course so far, our patient met 2 out of 4 listed criteria for pediatric pseudointestinal obstruction, persistently dilated loops of small intestine with air fluid and inability to maintain adequate nutrition and growth via enteral feed. Conclusion To conclude, we present a difficult case of PIPO, with early onset of abdominal distention, need for parenteral nutrition, and bladder involvement with uncertain prognosis. Nevertheless, early recognition of disorder leads to optimal management including formation of venting stoma, prevention of unnecessary repeated surgeries and better nutritional management.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A116
274 Screening for celiac disease among first-grade pupils using rapid point-of-care test, a prospective study
Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals with reported global prevalence in children from 0.31% to 0.9%. Despite the increasing prevalence of CD, many patients remain undiagnosed. Several point-of-care tests (POC) for CD have been developed that can be used as useful screening tool. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar county, Croatia using POC test. Methods: Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results: 1478 children were tested and none of them were tested positive with rapid test. In 10 children (0,6%) IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG and anti DGP antibodies. IgA deficiency was confirmed in 3 patients and in all 4 children CD has been excluded. Conclusion: In this, to our knowledge first prospective study in Croatia, we haven’t found children with celiac disease. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of rapid test in comparison with standard antibody CD testing.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A116
Open Access274 Screening for celiac disease among first-grade pupils using rapid point-of-care test, a prospective study
Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals with reported global prevalence in children from 0.31% to 0.9%. Despite the increasing prevalence of CD, many patients remain undiagnosed. Several point-of-care tests (POC) for CD have been developed that can be used as useful screening tool. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar county, Croatia using POC test. Methods: Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results: 1478 children were tested and none of them were tested positive with rapid test. In 10 children (0,6%) IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG and anti DGP antibodies. IgA deficiency was confirmed in 3 patients and in all 4 children CD has been excluded. Conclusion: In this, to our knowledge first prospective study in Croatia, we haven’t found children with celiac disease. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of rapid test in comparison with standard antibody CD testing.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A115.2-A116
273 Prevalence of upper gastrointestinal tract endoscopies at the pediatric clinic of the clinical hospital center rijeka from 2007 to 2017
Aim The aim of the study was to determine the frequency of individual indications, total number of esophagogastroduodenoscopies (EGDS) and pathohistological (PH) findings at the Pediatric Clinic, Clinical Hospital Center ( CHC ) Rijeka. The frequency of therapeutic interventions for foreign body extraction, the most common types of ingested objects, the frequency of ingestion of acid and alkalis, and the placement of PEG were also considered. Materials and Methods The medical records of all patients undergoing EGDS from January 2007 to December 2017 were reviewed retrospectively. In the analysis of the obtained data, the reasons for performing EGDS in each patient were recorded. The sample for PH analysis was taken based on the assesment of the physician who performed the examination (pediatric gastroenterologist). Results The total number of examinations performed was 1022. The most common indications for EGDS were: dyspepsia 32% (n =327), abdominal pain 21% (n= 211), and celiac disease 16% (n = 166). The most common endoscopic findings were : gastritis 50% (n =450), normal findings 35% (n = 325) and esophagitis 9% (n= 84). The most common PH findings were: normal 43% (n = 390), gastritis 23% (n=210), and duodenitis 15% (n =133). Of the total number of examinations, endoscopy was therapeutic in 10% (n= 98) of cases. The most common therapeutic indications were: foreign body ingestion 5% (n =51), PEG placement 3% (n= 35), and acid and alkali ingestion 1% (n=12). Conclusion The results obtainted are consistent with those of other studies and may indicate areas for additional education of staff and a starting point for future research on the topic.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A115.2-A116
Open Access273 Prevalence of upper gastrointestinal tract endoscopies at the pediatric clinic of the clinical hospital center rijeka from 2007 to 2017
Aim The aim of the study was to determine the frequency of individual indications, total number of esophagogastroduodenoscopies (EGDS) and pathohistological (PH) findings at the Pediatric Clinic, Clinical Hospital Center ( CHC ) Rijeka. The frequency of therapeutic interventions for foreign body extraction, the most common types of ingested objects, the frequency of ingestion of acid and alkalis, and the placement of PEG were also considered. Materials and Methods The medical records of all patients undergoing EGDS from January 2007 to December 2017 were reviewed retrospectively. In the analysis of the obtained data, the reasons for performing EGDS in each patient were recorded. The sample for PH analysis was taken based on the assesment of the physician who performed the examination (pediatric gastroenterologist). Results The total number of examinations performed was 1022. The most common indications for EGDS were: dyspepsia 32% (n =327), abdominal pain 21% (n= 211), and celiac disease 16% (n = 166). The most common endoscopic findings were : gastritis 50% (n =450), normal findings 35% (n = 325) and esophagitis 9% (n= 84). The most common PH findings were: normal 43% (n = 390), gastritis 23% (n=210), and duodenitis 15% (n =133). Of the total number of examinations, endoscopy was therapeutic in 10% (n= 98) of cases. The most common therapeutic indications were: foreign body ingestion 5% (n =51), PEG placement 3% (n= 35), and acid and alkali ingestion 1% (n=12). Conclusion The results obtainted are consistent with those of other studies and may indicate areas for additional education of staff and a starting point for future research on the topic.
- Open Access
GLUT1 Deficiency Syndrome—Early Treatment Maintains Cognitive Development? (Literature Review and Case Report)
Glucose transporter type 1 (GLUT1) is the most important energy carrier of the brain across the blood–brain barrier, and a genetic defect of GLUT1 is known as GLUT1 deficiency syndrome (GLUT1DS). It is characterized by early infantile seizures, developmental delay, microcephaly, ataxia, and various paroxysmal neurological phenomena. In most cases, GLUT1DS is caused by heterozygous single-nucleotide variants (SNVs) in the SLC2A1 gene that provoke complete or severe impairment of the functionality and/or expression of GLUT1 in the brain. Despite the rarity of these diseases, GLUT1DS is of high clinical interest since a very effective therapy, the ketogenic diet, can improve or reverse symptoms, especially if it is started as early as possible. We present a clinical phenotype, biochemical analysis, electroencephalographic and neuropsychological features of an 11-month-old boy with myoclonic seizures, hypogammaglobulinemia, and mildly impaired gross motor development. Using sequence analysis and deletion/duplication testing, deletion of an entire coding sequence in the SLC2A1 gene was detected. Early introduction of a modified Atkins diet maintained a seizure-free period without antiseizure medications and normal cognitive development in the follow-up period. Our report summarizes the clinical features of GLUT1 syndromes and discusses the importance of early identification and molecular confirmation of GLUT1DS as a treatable metabolic disorder.
Open AccessGLUT1 Deficiency Syndrome—Early Treatment Maintains Cognitive Development? (Literature Review and Case Report)
Glucose transporter type 1 (GLUT1) is the most important energy carrier of the brain across the blood–brain barrier, and a genetic defect of GLUT1 is known as GLUT1 deficiency syndrome (GLUT1DS). It is characterized by early infantile seizures, developmental delay, microcephaly, ataxia, and various paroxysmal neurological phenomena. In most cases, GLUT1DS is caused by heterozygous single-nucleotide variants (SNVs) in the SLC2A1 gene that provoke complete or severe impairment of the functionality and/or expression of GLUT1 in the brain. Despite the rarity of these diseases, GLUT1DS is of high clinical interest since a very effective therapy, the ketogenic diet, can improve or reverse symptoms, especially if it is started as early as possible. We present a clinical phenotype, biochemical analysis, electroencephalographic and neuropsychological features of an 11-month-old boy with myoclonic seizures, hypogammaglobulinemia, and mildly impaired gross motor development. Using sequence analysis and deletion/duplication testing, deletion of an entire coding sequence in the SLC2A1 gene was detected. Early introduction of a modified Atkins diet maintained a seizure-free period without antiseizure medications and normal cognitive development in the follow-up period. Our report summarizes the clinical features of GLUT1 syndromes and discusses the importance of early identification and molecular confirmation of GLUT1DS as a treatable metabolic disorder.
- Open Access
- 7 October 2019
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2019, 1-5
Is There a Role of Using a Rapid Finger Prick Antibody Test in Screening for Celiac Disease in Children?
Introduction. Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals. Despite the increasing prevalence of CD, many patients remain undiagnosed. Standard serology tests are expensive and invasive, so several point-of-care tests (POC) for CD have been developed. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar County, Croatia, using a POC test. Methods. A Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results. 1478 children were tested, and none of them were tested positive with a rapid test. In 10 children (0,6%), IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG, and anti-DGP antibodies. IgA deficiency was confirmed in 3 patients, and in all 4 children, CD has been excluded. Conclusion. Our results have not confirmed the usefulness of the POC test in screening the general population of first-grade schoolchildren. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of the rapid test in comparison with standard antibody CD testing.
- 7 October 2019
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2019, 1-5
Open AccessIs There a Role of Using a Rapid Finger Prick Antibody Test in Screening for Celiac Disease in Children?
Introduction. Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals. Despite the increasing prevalence of CD, many patients remain undiagnosed. Standard serology tests are expensive and invasive, so several point-of-care tests (POC) for CD have been developed. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar County, Croatia, using a POC test. Methods. A Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results. 1478 children were tested, and none of them were tested positive with a rapid test. In 10 children (0,6%), IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG, and anti-DGP antibodies. IgA deficiency was confirmed in 3 patients, and in all 4 children, CD has been excluded. Conclusion. Our results have not confirmed the usefulness of the POC test in screening the general population of first-grade schoolchildren. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of the rapid test in comparison with standard antibody CD testing.
- Open Access
- 1 December 2016
- Published by University of Rijeka, Faculty of Medicine in Medicina Fluminensis
- Vol. 52 (4) , 556-560
Habit cough – cause or consequence of gastroesophageal reflux disease?
Cilj: prikaz 15-godišnjeg pacijenta upućenog u našu Kliniku radi kroničnog kašlja i ezofagitisa. Prikaz slučaja: Petnaestogodišnji mladić patio je od dugotrajnog kašlja uz koji su se javljale i poteškoće gutanja....
- 1 December 2016
- Published by University of Rijeka, Faculty of Medicine in Medicina Fluminensis
- Vol. 52 (4) , 556-560
Open AccessHabit cough – cause or consequence of gastroesophageal reflux disease?
Cilj: prikaz 15-godišnjeg pacijenta upućenog u našu Kliniku radi kroničnog kašlja i ezofagitisa. Prikaz slučaja: Petnaestogodišnji mladić patio je od dugotrajnog kašlja uz koji su se javljale i poteškoće gutanja....